Company Filing History:
Years Active: 2012-2018
Title: Richard Aleck Jorgensen: Innovator in Antibody Technology
Introduction
Richard Aleck Jorgensen is a notable inventor based in San Jose, CA. He has made significant contributions to the field of biotechnology, particularly in the development of methodologies for obtaining antibodies. With a total of 4 patents to his name, Jorgensen's work has the potential to impact various applications in medical research and diagnostics.
Latest Patents
One of Jorgensen's latest patents is titled "Method of obtaining antibodies of interest and nucleotides encoding same." This invention presents a methodology that allows for the selection of a single cell or cells of interest from a vast number of cells. The process enables the rapid and efficient acquisition of specific information from these cells. In this methodology, a large number of antibody-producing cells, such as plasma cells, are separated and placed in individual wells. These cells are then allowed to produce antibodies, which are subsequently contacted with a protein bound to a solid surface, such as a well top. The protein binds universally and specifically to the antibodies in the wells. The surface or well tray top is designed with addresses that correspond to each individual well containing a cell producing antibodies.
Career Highlights
Richard Aleck Jorgensen is currently associated with Single Cell Technology, Inc., where he continues to advance his research and innovations. His work in antibody technology is paving the way for new methodologies that can enhance the efficiency of antibody production and analysis.
Collaborations
Jorgensen has collaborated with notable colleagues, including Chun-Nan Chen and James O Bowlby, Jr. These collaborations have contributed to the development of innovative solutions in the field of biotechnology.
Conclusion
Richard Aleck Jorgensen is a prominent inventor whose work in antibody technology is making significant strides in the biotechnology sector. His innovative methodologies have the potential to revolutionize the way antibodies are obtained and utilized in research and medical applications.